OIA response: Male sex change hormones data

Response to an Official Information Act request for data on sex change hormones for males.

28 November 2019

[name and contact details redacted]

Dear [name redacted]

REQUEST FOR INFORMATION

Thank you for your request dated 1 November 2019 under the Official Information Act 1982 (OIA).  You asked for data on:

biological males that are being prescribed:

  • oestrogen,
  • progesterones,
  • GnRH Agonists (ie Lupron),
  • anti-androgens (spironolactone, bicalumide, flutamide, finasteride).

Broken by type, age, financial year.

The requested data is provided on the following page. Please note that this is for medicines dispensed, as data on the number of prescriptions written is not collected.

PHARMAC has used <10 to denote where patient numbers are in single figures. This is an approach that PHARMAC generally takes across data requests to protect patient privacy in cases where patients may be able to be identified.  In the particular circumstances of your request, where the numbers are less than 10, this data will not be provided, because we consider this is necessary to protect the privacy of natural persons (section 9(2)(a)) given the sensitive nature of the data requested and the patient population to which the data relates.

As required under the OIA, we considered whether, in the circumstances, the withholding of this information was outweighed by other considerations which render it desirable, in the public interest, to make this information available.  In this case we did not consider that the public interest outweighed the reasons for withholding the information.  Please note you have the right, by way of complaint under section 28(3) of the OIA to an Ombudsman, to seek an investigation and review of our decision.

We trust that this information answers your queries.  We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website.  Please get in touch with us if you have any questions about this.

Yours sincerely

Alison Hill
Director, Engagement and Implementation

Male hormone prescriptions by age

Note that there were no progesterone prescriptions dispensed for males of any age.

AGE 

0

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

Total

2014/15

Anti androgens

14

16

<10

<10

11

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

98

 

Gnrh analogues

<10

 0

 0

<10

<10

<10

<10

<10

<10

<10

<10

<10

11

<10

18

70

 

Oestrogens

 0

0

2015/16

Anti androgens

16

17

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

11

101

 

Gnrh analogues

<10

<10

<10

<10

<10

<10

<10

<10

<10

13

18

15

76

 

Oestrogens

0

2016/17

Anti androgens

16

10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

70

 

Gnrh analogues

<10

<10

<10

<10

<10

<10

<10

<10

15

16

24

20

100

 

Oestrogens

0

2017/18

Anti androngens

11

18

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

11

80

 

Gnrh analogues

 0

<10

<10

<10

<10

<10

12

10

23

33

25

22

144

 

Oestrogens

 0

 0

0

2018/19

Anti androngens

18

11

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

<10

10

91

 

Gnrh analogues

<10

<10

<10

<10

<10

17

19

23

30

40

24

178

 

Oestrogens

<10

 0

<10

AGE 

19 to 25

26 to 30

31 to 35

36 to 40

41 to 45

46 to 50

51 to 55

56 to 60

61 to 65

66 to 70

above 70

Total

2014/15

Anti androgens

62

61

95

138

282

498

803

1079

1472

1900

7169

13,559

 

Gnrh analogues

14

<10

<10

<10

11

19

53

171

358

783

4107

5528

 

Oestrogens

<10

<10

 0 

<10

<10

<10

<10

<10

<10

<10

16

2015/16

Anti androngens

70

73

89

147

329

519

812

1182

1614

1987

7498

14,320

 

Gnrh analogues

34

<10

<10

<10

<10

23

55

175

421

750

4377

5852

 

Oestrogens

<10

<10

<10

<10

<10

<10

<10

<10

<10

13

2016/17

Anti androgens

86

79

106

161

329

568

879

1222

1649

2232

7995

15,306

 

Gnrh analogues

52

<10

<10

<10

<10

30

64

186

425

907

4617

6297

 

Oestrogens

  0 

<10

<10

<10

<10

<10

<10

<10

<10

14

2017/18

Anti androgens

90

85

113

186

360

573

935

1340

1698

2263

8377

16,020

 

Gnrh analogues

50

<10

<10

<10

<10

23

71

202

483

976

4880

6705

 

Oestrogens

 0

<10

<10

<10

<10

<10

<10

10

2018/19

Anti androgens

112

98

146

205

376

652

1008

1500

1798

2413

8894

17,202

 

Gnrh analogues

47

<10

<10

<10

<10

26

74

201

516

1012

5132

7031

 

Oestrogens

<10

<10

<10

<10

<10

<10

<10